Investigating how a specific protein affects brain activity and seizure risk
The mitochondrial Ca2+ uniporter in the regulation of neural activity and susceptibility to seizures
This study is looking at how a specific protein in brain cells affects brain activity and seizures, with the goal of finding new ways to help people who have epilepsy that doesn't respond to regular treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10986102 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the mitochondrial Ca2+ uniporter (MCU) in the brain, particularly how it influences neural activity and the likelihood of seizures. By studying the effects of MCU on synaptic function and calcium signaling, researchers aim to identify new therapeutic targets for patients with refractory epilepsy, a condition that does not respond to standard treatments. The approach includes both in vivo and in vitro experiments to observe the anticonvulsant effects of manipulating MCU in specific types of neurons. This could lead to innovative treatments that improve seizure control and cognitive outcomes for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with refractory epilepsy who have not responded to conventional anticonvulsant medications.
Not a fit: Patients with well-controlled epilepsy or those who do not have epilepsy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve seizure control and reduce the risk of sudden unexpected death in epilepsy (SUDEP) for patients with refractory epilepsy.
How similar studies have performed: Previous studies have shown promising results in manipulating calcium signaling pathways for seizure control, suggesting that this approach may yield significant advancements.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Usachev, Yuriy M — University of Iowa
- Study coordinator: Usachev, Yuriy M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.